[The new possibilities to control allergic inflammatory processes]

Henryk Tchórzewski1

  • 1Zakład Immunologii Klinicznej Instytutu Centrum Zdrowia Matki Polki oraz Zakład Patofizjologii i Immunologii Uniwersytetu Medycznego w Łodzi.

Insights

Apoptosis, programmed cell death, is crucial for immune system regulation. Dysfunctional apoptosis can lead to allergies and autoimmunity, but targeted apoptosis may treat allergic diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Genetics

Background:

  • Inflammation is linked to immune and allergic reactions.
  • Apoptosis (programmed cell death) eliminates inflammatory cells.
  • Apoptosis is vital for immune system development and regulation.

Purpose of the Study:

  • To explore the role of apoptosis in immune regulation and allergic diseases.
  • To investigate the link between apoptosis dysfunction and autoimmunity/allergy.
  • To assess the therapeutic potential of induced apoptosis in allergic conditions.

Main Methods:

  • Review of existing literature on apoptosis and immune responses.
  • Analysis of genetic regulation of apoptosis in immune cells.
  • Examination of T cell apoptosis in the thymus and periphery.

Main Results:

  • Apoptosis regulates immune system maturation and T cell elimination.
  • Deviations in apoptosis can cause loss of tolerance, leading to autoimmunity and allergy.
  • Impaired function of regulatory T cells (CD4+ and CD25+) is implicated.

Conclusions:

  • Apoptosis is a critical mechanism for preventing and resolving inflammation.
  • Dysregulated apoptosis contributes to the development of allergic and autoimmune diseases.
  • Targeted induction of apoptosis presents a potential therapeutic strategy for allergic diseases.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions02:06

Allergic Reactions

Overview
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...